期刊文献+

甲基多巴透过POPC磷脂双层膜过程的分子动力学模拟 被引量:3

Molecular Dynamics Simulation of the Permeation of Methyldopa through POPC Phospholipid Bilayer Membrane
下载PDF
导出
摘要 采用分子动力学模拟研究甲基多巴分子透过磷脂双层膜的动力学机制.研究所采用的磷脂双层膜是一种卵磷脂脂质分子双层膜,即1-棕榈酰-2-油酰-卵磷脂(POPC)双层膜,分子动力学模拟基于Gromacs程序.通过分子动力学模拟获得甲基多巴透过POPC双层膜的自由能垒是99.9 kJ·mol-1(310 K),显示甲基多巴分子可以透过细胞生物膜.模拟获得甲基多巴在POPC双层膜中间层扩散运动的自由能垒是16.9-27.7 kJ·mol-1(310 K),证明甲基多巴分子在细胞膜中间层容易扩散.研究工作加深了对甲基多巴治疗高血压病机制的理解,促进研发治疗高血压病的新药物. The molecular dynamics mechanism for methyldopa permeation through the phospholipid bilayer membrane has been studied by molecular dynamics simulation. The phospholipid bilayer membrane used in the work was one type of lecithin phospholipid bilayer membrane called the 1-palmitoyl-2-oleoyl-glycero-3- phosphate dylcholine (POPC) bilayer membrane, and the molecular dynamics simulation was performed with the Gromacs program. The free energy barrier for methyldopa to permeate through the POPC bilayer membrane was 99.9 kJ·mo1^-1 (310 K) from the molecular dynamics simulation, suggesting that methyldopa is capable of permeating through the cell membrane. The free energy barrier for methyldopa to diffuse through the POPC bilayer membrane was 16.9-27.7 kJ· mol^-1 (310 K), which indicates that it is easy for methyldopa to diffuse through the cell membrane. Therefore, the results of the free energy barrier give information of the mechanism for methyldopa to metabolize in the human body. Furthermore, the results help to understand the mechanism for methyldopa in treating hypertension disease, and have significance for developing new drugs to control hypertension.
出处 《物理化学学报》 SCIE CAS CSCD 北大核心 2014年第10期1947-1956,共10页 Acta Physico-Chimica Sinica
基金 国家自然科学基金(21163024) 云南省教育厅科学研究基金(2013Y529)资助~~
关键词 甲基多巴 高血压 细胞膜 POPC 分子模拟 分子动力学 Methyldopa Hypertension Cell membrane POPC Molecular simulation Moleculardynamics
  • 相关文献

参考文献72

  • 1Swift, P. A.; Macgregor, G. A. Journal of Renin-Angiotensin-Aldosterone System 2002, 3, 103. doi: 10.3317/jraas.2002.010.
  • 2Chobanian, A. V.; Bakris, G. L.; Black, H. R.; Cushman,W. C.; Green, L. A.; Izzo, J. L.; Jones, D.W.; Materson, B. J.; Oparil, S.;Wright, J. T.; Roccella, E. J. Hypertension 2003, 42, 1206. doi: 10.1161/01.HYP.0000107251.49515.c2.
  • 3Vedin, J. A.;Wilhelmsson, C. E.Werko, L. Brit. Heart J. 1973, 35, 1285. doi: 10.1136/hrt.35.12.1285.
  • 4Dollery, C. T.; Harington, M.; Hodge, J. V. Brit. Heart J. 1963, 25, 670. doi: 10.1136/hrt.25.5.670.
  • 5Bosworth, H. B.; Olsen, M. K.; Oddone, E. Z. Am. Heart. J. 2005, 149 (5), 795.
  • 6Arauz-Pacheco, C.; Parrott, M. A.; Raskin, P. Diabetes Care 2002, 25, 134. doi: 10.2337/diacare.25.1.134.
  • 7Lant, A. Drugs 1986, 31 (4), 40.
  • 8Bissoli, N. S.; Vasqufz, E. C.; Cabral, A. M. Pharmacol. Res. 1996, 33, 47. doi: 10.1006/phrs.1996.0008.
  • 9Warram, J. H.; Laffel, L. M.; Valsania, P.; Christlieb, A. R.; Krolewski, A. S. Arch Intern. Med. 1991, 151 (7), 1350. doi: 10.1001/archinte.1991.00400070114014.
  • 10Langer, S. Z.; Cavero, I.; Massingham, R. Hypertension 1980, 2, 372. doi: 10.1161/01.HYP.2.4.372.

二级参考文献62

  • 1Li, F.; Shu, S. Y.; Bao, X. M. Chin. J. Neurosci. 2003, 19, 405.
  • 2Carlsson, A.; Waters, N.; Waters, S.; Carlsson, M. L. Brain Research Reviews 2000, 31, 342. doi: 10.1016/S0165-0173(99)00050-8.
  • 3Suri, R. E.; Bargas, J.; Arbib, M. A. Neuroscience 2001, 103, 65. doi: 10.1016/S0306-4522(00)00554-6.
  • 4Salum, C.; Roque, S. A.; Pickering, A. Neurocomputing 1999, 26, 845.
  • 5Xu, S. C.; Shi, G. J.; Chi, S. M. The Active Site Residues and the Molecular Channels for Dopamine within D3R Membrane Protein. The 28thCCS (Chinese Chemical Society) Congress, Sichuan University, Chengdu, China, April 13-16, 2012.
  • 6Bian, F. Y.; Shi, G. J.; Chi, S. M.; Xu, S. C. The Perspective Insight into the Pathology of Parkinsonism Using the Molecular Channel Theory of Dopamine inside its Receptor Membrane Protein. Chinese Chemical Society at the Second National Conference on Bio-physical Chemistry (NCBPC2) and the International Forum on Development of Chinese Bio-physical Chemistry, Wuhan University, Wuhan, China, Oct 15-18, 2012.
  • 7Amy, R. M.; Raul, R. G.; Marc, G. C.; Beverly, H. K. Cell 1999, 98, 427. doi: 10.1016/S0092-8674(00)81972-8.
  • 8Coyle, J. T.; Puttafreken, P. Science 1993, 262, 689. doi: 10.1126/science.7901908.
  • 9Coyle, J. T. Harv. Rev. Psychiatry 1996, 3, 241. doi: 10.3109/10673229609017192.
  • 10Kim, J. S.; Konrhuber, H. H.; Sehmid-Burgk, W.; Holzmuller, B. Neurosci Lett. 1980, 20, 379. doi: 10.1016/0304-3940(80)90178-0.

共引文献5

同被引文献10

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部